Search - tctmd.com

Displaying 21 - 40 of 43

Sort: Relevancy | Date

News Daily News

CMS Weighs Medicare Coverage at the Time of FDA Approval for Breakthrough Devices

Michael O'Riordan

October 30, 2020

News Daily News

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Michael O'Riordan

October 28, 2020

News Conference News TCT 2020

Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up

Michael O'Riordan

October 23, 2020

Presentation TCT 2020

SCOPE I: One-year outcomes of a randomized trial comparing a self-expanding to a balloon-expandable transcatheter aortic valve

Presenter: Thomas Walther

October 17, 2020

News Conference News TCT 2020

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Michael O'Riordan

October 15, 2020

Presentation TCT 2020

Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: the SCOPE II randomised clinical trial

Presenter: Corrado Tamburino

October 15, 2020

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Shelley Wood

October 09, 2020

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Todd Neale

December 10, 2019

News Conference News TCT 2019

Predicting Final Valve Position After TAVR: Different Devices, Different Success

Michael O'Riordan

October 07, 2019

News Conference News TCT 2019

Portico Noninferior to Commercial TAVR Valves in IDE Study

Caitlin E. Cox

September 27, 2019

News Conference News TCT 2019

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Marcus A. Banks

September 27, 2019

Presentation TCT 2019

Lessons From the SCOPE I Study and the ACURATE neo Body of Evidence

Presenter: Thomas Pilgrim

September 27, 2019

Presentation TCT 2019

SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis

Presenter: Jonas Lanz

September 27, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

News Conference News ESC 2019

Mortality in Untreated Moderate AS Keeps Pace With What’s Seen in More Severe Disease

L.A. McKeown

September 05, 2019

News Daily News

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

Yael L. Maxwell

June 11, 2019

News Daily News

Most Cardiovascular Drugs Can Be Safely Used in Pregnancy, Review Suggests

Todd Neale

February 01, 2019

News Daily News

‘We Have to Go to Them’: New Global Initiative for Treating Rheumatic Heart Disease

Michael O'Riordan

August 06, 2018

News Daily News

Coronary Procedures After TAVR: New Practical Guide Reviews Tools, Techniques

Yael L. Maxwell

March 23, 2018

Advertisement

CMS Weighs Medicare Coverage at the Time of FDA Approval for Breakthrough Devices

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up

SCOPE I: One-year outcomes of a randomized trial comparing a self-expanding to a balloon-expandable transcatheter aortic valve

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: the SCOPE II randomised clinical trial

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Predicting Final Valve Position After TAVR: Different Devices, Different Success

Portico Noninferior to Commercial TAVR Valves in IDE Study

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Lessons From the SCOPE I Study and the ACURATE neo Body of Evidence

SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis

TCT 2019 Day Two: Transcatheter Valves, New and Old

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Mortality in Untreated Moderate AS Keeps Pace With What’s Seen in More Severe Disease

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

Most Cardiovascular Drugs Can Be Safely Used in Pregnancy, Review Suggests

‘We Have to Go to Them’: New Global Initiative for Treating Rheumatic Heart Disease

Coronary Procedures After TAVR: New Practical Guide Reviews Tools, Techniques

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content